Clinical symptoms and radiological sequels after SARS-CoV-2 pneumonia: A longitudinal study

##plugins.themes.academic_pro.article.sidebar##

Published Dec 27, 2025
https://doi.org/10.62438/tunismed.v103i10.5861
Download
pdf
Vol. 103 No. 10 (2025): Tunis Med Oct 2025

##plugins.themes.academic_pro.article.main##

Hela Cherif
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
https://orcid.org/0000-0002-2086-918X
Ghada Berkaoui
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Soumaya Debiche
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Ferdaous Yangui
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
https://orcid.org/0000-0003-2465-0019
Mehdi Charfi
Imaging Department , Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Lamine Chikhaoui
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Salma Mokaddem
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia
Mohamed Ridha Charfi
Pulmonology Department, Health and environment in security forces research laboratory LR211NT01, Internal Security Forces Hospital, La Marsa, Tunis, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunisia

Abstract





Introduction: The long-term effects of COVID-19 have been recognized as a significant public health issue, particularly for hospitalized patients who may experience persistent symptoms and lung complications. This study aimed to determine the prevalence of persistent clinical symptoms and determine the predictive factors of persistent CT scan abnormalities (PCA) after COVID-19 pneumonia.


Methods: This was a longitudinal cohort study of patients followed up after being hospitalized for confirmed SARS-CoV-2 pneumonia. Patients were assessed for persistent clinical symptoms at one month and for PCA at four months. A logistic regression model was employed to assess the relationship between PCA and explanatory variables.


Results:  A total of 240 patients were included. The sex ratio was 1.75, with a mean age of 57.6(± 11.5) years. The median length of stay was 10 [7–15] days. Initial CT scans revealed severe impairment in 23%. After one month, 75.8% had at least one persistent symptom. Hyperventilation syndrome was diagnosed in 15.4% of patients. At four-month follow-up, CT scan showed that 65% of patients had PCA.


Factors associated with PCA, included age (p=0.001), initial dyspnea (p=0.021), length of hospital stay (p=0.001), an initial CT Severity Score (CTSS)≥ 50 (p=0.047), a low FEV1 (p=0.022), a low Total Lung capacity (TLC) (p=0.035) and impairment in DLCO (p=0.012).  Logistic regression identified older age (OR=1.05 [1.02;1.08], p= 0.01), longer hospital stay (OR=1.12 [1.04;1.21], p= 0.003), and dyspnea (OR=3.11 [1.28;7.52],p= 0.012) as independent predictive factors .....(abstract truncated at 250 words)





Keywords:

SARS-CoV-2, Pneumonia, Sequels, Chest CT scan, Respiratory Function Tests

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Bio Medica Atenei Parm. 2020 91(1):157-160.
  2. Çelik İ, Öztürk R. From asymptomatic to critical illness: decoding various clinical stages of COVID-19. Turk J Med Sci. 2021;51(7).
  3. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Apr;27(4):601–15.
  4. Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463–72.
  5. Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020 Jul;56(1):2001494.
  6. Sakai T, Hoshino C, Hirao M, Nakano M, Takashina Y, Okawa A. Rehabilitation of Patients with Post-COVID-19 Syndrome: A Narrative Review. Prog Rehabil Med. 2023;(8):20230017.
  7. Mahler DA, Wells CK. Evaluation of Clinical Methods for Rating Dyspnea. Chest. 1988 Mar;93(3):580–6.
  8. Lewis RA, Howell JB. Definition of the hyperventilation syndrome. Bull Eur Physiopathol Respir. 1986;22(2):201–5.
  9. Alghamdi M, Hunt N. Psychometric properties of the Arabic Posttraumatic Diagnostic Scale for DSM–5 (A-PDS-5). Traumatology. 2020 Mar;26(1):109–16.
  10. Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM‐5 (PCL‐5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489–98.
  11. Ashbaugh AR, Houle-Johnson S, Herbert C, El-Hage W, Brunet A. Psychometric Validation of the English and French Versions of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5). Mazza M, editor. PLOS ONE. 2016 Oct 10;11(10):e0161645.
  12. Aliaë A R Mohamed-Hussein, Sayed IG, Saad M. Post Covid-19 functional status score, Arabic version. 2020 [cited 2023 Nov 8]; Available from: http://rgdoi.net/10.13140/RG.2.2.24997.32488
  13. Klok FA, Boon GJAM, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. 2020 Jul;56(1):2001494.
  14. Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, et al. Recommendations for a Standardized Pulmonary Function Report. An Official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017 Dec 1;196(11):1463–72.
  15. Stanojevic S, Kaminsky DA, Miller MR, Thompson B, Aliverti A, Barjaktarevic I, et al. ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022 Jul;60(1):2101499.
  16. Hall GL, Filipow N, Ruppel G, Okitika T, Thompson B, Kirkby J, et al. Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry. Eur Respir J. 2021 Mar;57(3):2000289.
  17. Almasi Nokiani A, Shahnazari R, Abbasi MA, Divsalar F, Bayazidi M, Sadatnaseri A. CT severity score in COVID-19 patients, assessment of performance in triage and outcome prediction: a comparative study of different methods. Egypt J Radiol Nucl Med. 2022 Dec;53(1):116.
  18. Yang R, Li X, Liu H, Zhen Y, Zhang X, Xiong Q, et al. Chest CT Severity Score: An Imaging Tool for Assessing Severe COVID-19. Radiol Cardiothorac Imaging. 2020 Apr 1;2(2):e200047.
  19. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: Glossary of Terms for Thoracic Imaging. Radiology. 2008 Mar;246(3):697–722.
  20. Cellai M, O’Keefe JB. Characterization of Prolonged COVID-19 Symptoms in an Outpatient Telemedicine Clinic. Open Forum Infect Dis. 2020 Oct 1;7(10):ofaa420.
  21. Jacobs LG, Gourna Paleoudis E, Lesky-Di Bari D, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. Madeddu G, editor. PLOS ONE. 2020 Dec 11;15(12):e0243882.
  22. Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, et al. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med. 2020 Nov;174:106197.
  23. Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022 May;28(5):657–66.
  24. Taverne J, Salvator H, Leboulch C, Barizien N, Ballester M, Imhaus E, et al. High incidence of hyperventilation syndrome after COVID-19. J Thorac Dis. 2021 Jun;13(6):3918–22.
  25. Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, d’Ortho MP, et al. Hyperventilation: A Possible Explanation for Long-Lasting Exercise Intolerance in Mild COVID-19 Survivors? Front Physiol. 2021 Jan 18;11:614590.
  26. Van Dixhoorn J, Duivenvoorden HJ. Efficacy of Nijmegen questionnaire in recognition of the hyperventilation syndrome. J Psychosom Res. 1985 Jan;29(2):199–206.
  27. Allado E, Poussel M, Hamroun A, Moussu A, Kneizeh G, Hily O, et al. Is There a Relationship between Hyperventilation Syndrome and History of Acute SARS-CoV-2 Infection? A Cross-Sectional Study. Healthcare. 2022 Oct 28;10(11):2154.
  28. Grammatopoulou EP, Skordilis EK, Georgoudis G, Haniotou A, Evangelodimou A, Fildissis G, et al. Hyperventilation in asthma: A validation study of the Nijmegen Questionnaire – NQ. J Asthma. 2014 Oct;51(8):839–46.
  29. Fekih-Romdhane F, Ghrissi F, Abbassi B, Cherif W, Cheour M. Prevalence and predictors of PTSD during the COVID-19 pandemic: Findings from a Tunisian community sample. Psychiatry Res. 2020 Aug;290:113131.
  30. American Psychiatric Association, American Psychiatric Association, editors. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington, D.C: American Psychiatric Association; 2013. 947 p.
  31. Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J. 2020 Jun;55(6):2001217.
  32. Hellemons ME, Huijts S, Bek LM, Berentschot JC, Nakshbandi G, Schurink CAM, et al. Persistent Health Problems beyond Pulmonary Recovery up to 6 Months after Hospitalization for COVID-19: A Longitudinal Study of Respiratory, Physical, and Psychological Outcomes. Ann Am Thorac Soc. 2022 Apr;19(4):551–61.
  33. Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, et al. Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Netw Open. 2021 Jan 27;4(1):e2036142.
  34. So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm Med. 2021 Dec;21(1):97.
  35. Tabatabaei SMH, Rajebi H, Moghaddas F, Ghasemiadl M, Talari H. Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? Emerg Radiol. 2020 Dec;27(6):711–9.
  36. Parry AH, Wani AH, Shah NN, Jehangir M. Medium-term chest computed tomography (CT) follow-up of COVID-19 pneumonia patients after recovery to assess the rate of resolution and determine the potential predictors of persistent lung changes. Egypt J Radiol Nucl Med. 2021 Dec;52(1):55.
  37. Vijayakumar B, Tonkin J, Devaraj A, Philip KEJ, Orton CM, Desai SR, et al. CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology. 2022 May;303(2):444–54.
  38. Rincon-Alvarez E, Gonzalez-Garcia M, Ali-Munive A, Casas A, Proaños NJ, Giraldo-Cadavid LF, et al. Risk factors for persistent tomographic abnormalities at 6 months of follow-up in a cohort of hospitalized patients with moderate and severe COVID-19 living at high altitude. Front Med. 2023 Feb 8;10:1110535.
  39. Van Den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive Health Assessment 3 Months After Recovery From Acute Coronavirus Disease 2019 (COVID-19). Clin Infect Dis. 2021 Sep 7;73(5):e1089–98.
  40. Lerum TV, Aaløkken TM, Brønstad E, Aarli B, Ikdahl E, Lund KMA, et al. Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19. Eur Respir J. 2021 Apr;57(4):2003448.
  41. Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. 2021 Apr;57(4):2003690.
  42. Mohamed Hussein AR, Saad M, Zayan H, Abdelsayed M, Moustafa M, Ezzat A, et al. Post-COVID-19 functional status: Relation to age, smoking, hospitalization, and previous comorbidities. Ann Thorac Med. 2021;16(3):260.
  43. Menter T, Haslbauer JD, Nienhold R, Savic S, Hopfer H, Deigendesch N, et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction. Histopathology. 2020 Aug;77(2):198–209.
  44. Martini K, Larici AR, Revel MP, Ghaye B, Sverzellati N, Parkar AP, et al. COVID-19 pneumonia imaging follow-up: when and how? A proposition from ESTI and ESR. Eur Radiol. 2022 Apr;32(4):2639–49.